91亚色传媒

Lipid News

Don鈥檛 game the system 鈥 be the system

Binks Wattenberg
Oct. 1, 2016

Who here is tired of exchanging tales of woe about grants not funded? Most of us, I suspect. Here I will describe how a group came together to develop a plan to give lipid-related grants a fair shake while we work to increase overall funding.

Lipid researchers often feel that their grants get dinged because of a lack of expertise in lipid biology in study sections. We know that when you are an expert in a field, you have a greater appreciation for the contributions that a particular grant can make to advance the field. With this in mind, colleagues and I started an initiative to ensure that grants with a lipid focus get the expert review that they (and all grants, really) deserve.

It is lost in the mists of time exactly when and where the idea nucleated, who was there, and why I could never get the hang of the secret handshake. But in time, a notion congealed — like a vat of warm triglyceride cooling in the breeze — that instead of kvetching about the lack of lipid expertise on the study sections, the lipid community could have a role in helping provide that expertise to the National Institutes of Health and other granting bodies.

And so the Lipid Research Division, or LRD (pronounced “lard,” of course), was born. Here, I will focus on how we have leveraged the LRD to help with grant review. The effort showcases how the LRD serves as an important voice for the lipid community within the 91亚色传媒.

The first step was to establish a membership. The staff of the 91亚色传媒 has been phenomenal throughout this process, both in welcoming the LRD as part of the 91亚色传媒 and in providing the information technology expertise and access to their membership database that were essential. We queried the 91亚色传媒 membership for interest in joining the LRD and also included non-91亚色传媒 members to lasso them into the 91亚色传媒 fold. We established an LRD membership list of several hundred members.

The next step was crucial. We engaged with staffers at the Center for Scientific Review at the NIH. Our pitch was simple: We want to help provide expertise, not push for more funding for lipid grants.

Several LRD steering committee members already had informally spoken with study-section scientific review officers to see if they were receptive to getting suggestions for lipid-centric reviewers. The response was overwhelmingly positive. SROs have so much to deal with. Imagine having to tell a study section full of caffeine junkies that coffee would no longer be available at the meetings. Horrors! Only slightly less onerous is ensuring that each study section is populated by the requisite expertise to review 80 grants on diverse topics using a variety of techniques. SROs do heroic duty by attending national meetings, going through meeting programs, looking through the literature and querying their contacts. They were glad for the help.

Encouraged, we went right to the top, speaking with Richard Nakamura, who is the director of CSR. He thought the idea was sound and guided us as to the qualifications they look for in reviewers and what information they could use that would help SROs find the expertise they need.

With the help of Ed Marklin, the IT wizard at the 91亚色传媒, we used the awesome power of Survey Monkey to see who in the LRD fit the CRS’s criteria. Close to 50 of the LRD membership had NIH-eligible reviewing experience but currently were not serving. This was a treasure trove of potential lipid expertise. We transmitted the list to one of Nakamura’s advisers at the CSR, Christine Melchior, who since has customized the list for SROs for whom she is responsible.

We are not done. We also are thinking of granting bodies outside of the NIH, such as the National Science Foundation, Department of Defense and disease-specific foundations, that could use our list. We also know there are lipid experts out there who are eluding their NIH duties. We are tracking them down.

Which brings me to my last point, which is about participating in NIH review. The review process is only as good as the reviewers who wade through the grants. If an SRO invites you to review, even though you absolutely do not have the time, make some. Give up sleeping or eating: There is plenty of time for that after you retire. See you at study section. I will bring the coffee.

Enjoy reading 91亚色传媒 Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Binks Wattenberg

Binks Wattenberg is a professor in the department of biochemistry and molecular biology at Virginia Commonwealth University and a member of the 91亚色传媒 Today editorial advisory board.

Get the latest from 91亚色传媒 Today

Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Fat cells are a culprit in osteoporosis
Journal News

Fat cells are a culprit in osteoporosis

April 11, 2025

Scientists reveal that lipid transfer from bone marrow adipocytes to osteoblasts impairs bone formation by downregulating osteogenic proteins and inducing ferroptosis. Read more about this recent study from the Journal of Lipid Research.

Unraveling oncogenesis: What makes cancer tick?
91亚色传媒 Annual Meeting

Unraveling oncogenesis: What makes cancer tick?

April 7, 2025

Learn about the 91亚色传媒 2025 symposium on oncogenic hubs: chromatin regulatory and transcriptional complexes in cancer.

Exploring lipid metabolism: A journey through time and innovation
91亚色传媒 Annual Meeting

Exploring lipid metabolism: A journey through time and innovation

April 4, 2025

Recent lipid metabolism research has unveiled critical insights into lipid鈥損rotein interactions, offering potential therapeutic targets for metabolic and neurodegenerative diseases. Check out the latest in lipid science at the 91亚色传媒 annual meeting.

Melissa Moore to speak at 91亚色传媒 2025
91亚色传媒 Annual Meeting

Melissa Moore to speak at 91亚色传媒 2025

April 2, 2025

Richard Silverman and Melissa Moore are the featured speakers at the 91亚色传媒 annual meeting to be held April 12-15 in Chicago.

 A new kind of stem cell is revolutionizing regenerative medicine
Feature

A new kind of stem cell is revolutionizing regenerative medicine

April 1, 2025

Induced pluripotent stem cells are paving the way for personalized treatments to diabetes, vision loss and more. However, scientists still face hurdles such as strict regulations, scalability, cell longevity and immune rejection.

Engineering the future with synthetic biology
91亚色传媒 Annual Meeting

Engineering the future with synthetic biology

March 31, 2025

Learn about the 91亚色传媒 2025 symposium on synthetic biology, featuring applications to better human and environmental health.